Evidence map›Paper›PMID 40875125›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2025

Bimolecular Fluorescence Complementation Assay to Evaluate the Interaction Between SUMO and Its Target Proteins in Cells.

Maria Blanquer, Santiago Vidal, Rocío M Tolosa, Beatriz Rodríguez-Lemus, Montserrat Pérez-Pérez, Eva Pérez-Gómez, Dalkiria Campos, José A Herrera-Gavilán, Yanis H Bouzaher, Carmen Rivas

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Maria BlanquerCentro de Investigación en Medicina Molecular y Enfermedades Crónicas (CIMUS), Universidade de Santiago de Compostela and Instituto de Investigaciones Sanitarias (IDIS), Santiago de Compostela, Spain.
Santiago VidalDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Rocío M TolosaCentro de Investigación en Medicina Molecular y Enfermedades Crónicas (CIMUS), Universidade de Santiago de Compostela and Instituto de Investigaciones Sanitarias (IDIS), Santiago de Compostela, Spain.
Beatriz Rodríguez-LemusCentro de Investigación en Medicina Molecular y Enfermedades Crónicas (CIMUS), Universidade de Santiago de Compostela and Instituto de Investigaciones Sanitarias (IDIS), Santiago de Compostela, Spain.
Montserrat Pérez-PérezCentro de Investigación en Medicina Molecular y Enfermedades Crónicas (CIMUS), Universidade de Santiago de Compostela and Instituto de Investigaciones Sanitarias (IDIS), Santiago de Compostela, Spain.
Eva Pérez-GómezCentro de Investigación en Medicina Molecular y Enfermedades Crónicas (CIMUS), Universidade de Santiago de Compostela and Instituto de Investigaciones Sanitarias (IDIS), Santiago de Compostela, Spain.
Dalkiria CamposGrupo de Biología Celular y Molecular de Arbovirus, Departamento de Genómica y Proteómica, Instituto Conmemorativo Gorgas de Estudios de la Salud, Panamá, Panama.
José A Herrera-GavilánCentro de Investigación en Medicina Molecular y Enfermedades Crónicas (CIMUS), Universidade de Santiago de Compostela and Instituto de Investigaciones Sanitarias (IDIS), Santiago de Compostela, Spain.
Yanis H BouzaherCentro de Investigación en Medicina Molecular y Enfermedades Crónicas (CIMUS), Universidade de Santiago de Compostela and Instituto de Investigaciones Sanitarias (IDIS), Santiago de Compostela, Spain.
Carmen RivasCentro de Investigación en Medicina Molecular y Enfermedades Crónicas (CIMUS), Universidade de Santiago de Compostela and Instituto de Investigaciones Sanitarias (IDIS), Santiago de Compostela, Spain. mcarmen.rivas@usc.es.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

SUMO can be covalently linked to specific substrates and can also interact noncovalently with proteins through SUMO-interacting motifs. SUMO modulates the activity, stability, or subcellular localization of its substrates, which results in the regulation of different cellular processes, including cell proliferation, immunity, and apoptosis. In addition, many viruses have developed strategies to exploit the SUMOylation machinery of the cell to modify their own proteins and facilitate virus replication. A technique that enables the determination of the interaction and subcellular localization of the interaction between SUMO and a specific substrate could be useful to understand the function of SUMO interaction in different cellular pathways and virus replication. The BiFC assay is a technique based on the reconstitution of a fluorescent protein that can reveal direct protein-protein interactions and the subcellular localization of the interaction in live or fixed cells. This technique consists of fusing the proteins of interest to each of the two halves of a fluorescent protein, resulting in nonfluorescent fusion proteins, so that if interaction occurs, the active fluorophore will be reconstituted and, consequently, a fluorescence signal could be detected. In this chapter, we describe the use of the BiFC technique to assay the noncovalent interaction of SUMO2 with a protein in cells, using the Ebola VP24 protein as a model, highlighting a potential pitfall when evaluating SUMO interactions.

Indexed as

Protein Interaction MappingSmall Ubiquitin-Related Modifier ProteinsSUMO-1 ProteinHumansLuminescent ProteinsMicroscopy, FluorescenceProtein BindingRecombinant Fusion ProteinsSumoylationLuminescent ProteinsRecombinant Fusion ProteinsSmall Ubiquitin-Related Modifier ProteinsSUMO-1 ProteinBiFCLiving cellProteinProtein fragment complementation assayprotein interactionsSUMO

Identifiers

PMID40875125

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.